AI assistant
REPLIGEN CORP — Director's Dealing 2014
May 6, 2014
30826_dirs_2014-05-06_2eab23de-fe4d-4f45-8636-36df68a091ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2014-05-05
Reporting Person: Hunt Anthony (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-05 | Common Stock | A | 25000 | — | Acquired | 25000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-05 | Stock Option (Right to Buy) | $16.55 | A | 50000 | Acquired | 2024-05-05 | Common Stock (50000) | Direct |
Footnotes
F1: Mr. Hunt was awarded 25,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. 5,000 Restricted Stock Units vest on each of the following dates: 5/05/2015, 5/05/2016, 5/05/2017, 5/05/2018 and 5/05/2019. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
F2: 10,000 shares vest and become exercisable on each of the following dates: 5/05/2015, 5/05/2016, 5/05/2017, 5/05/2018 and 5/05/2019.